Dr Niven R Narain

Co-founder, President & CEO, Berg Health

Dr. Niven R. Narain is Co-founder, President & CEO of BERG, LLC, a Boston-based biopharma driving next-generation drug and diagnostic development by combining patient-driven biology and Bayesian AI. He has been recognized as a pioneer in technology development at the intersection of Biology and AI, and is the inventor of the Interrogative Biology® platform that has unraveled actionable disease insight leading to both de novo and repurposed development. He has overseen development of deep pipeline in oncology, metabolic, rare, and CNS diseases, namely BPM 31510 currently in Phase 2 trials for cancer, covered by over 550 issued and pending US and international patents.